185 related articles for article (PubMed ID: 29492694)
1. The inhibition of invasion of human melanoma cells through N-cadherin knock-down.
Ciołczyk-Wierzbicka D; Laidler P
Med Oncol; 2018 Feb; 35(4):42. PubMed ID: 29492694
[TBL] [Abstract][Full Text] [Related]
2. Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway.
Rieger-Christ KM; Lee P; Zagha R; Kosakowski M; Moinzadeh A; Stoffel J; Ben-Ze'ev A; Libertino JA; Summerhayes IC
Oncogene; 2004 Jun; 23(27):4745-53. PubMed ID: 15122336
[TBL] [Abstract][Full Text] [Related]
3. mTOR inhibitor everolimus reduces invasiveness of melanoma cells.
Ciołczyk-Wierzbicka D; Gil D; Zarzycka M; Laidler P
Hum Cell; 2020 Jan; 33(1):88-97. PubMed ID: 31586300
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of cell proliferation using silencing of N-cadherin gene by siRNA process in human melanoma cell lines.
Ciołczyk-Wierzbicka D; Gil D; Laidler P
Curr Med Chem; 2012; 19(1):145-51. PubMed ID: 22300088
[TBL] [Abstract][Full Text] [Related]
5. Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.
Menakongka A; Suthiphongchai T
World J Gastroenterol; 2010 Feb; 16(6):713-22. PubMed ID: 20135719
[TBL] [Abstract][Full Text] [Related]
6. DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF-κB pathway.
Poudel B; Lee YM; Kim DK
Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):292-8. PubMed ID: 25733533
[TBL] [Abstract][Full Text] [Related]
7. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel small compounds that restore E-cadherin expression and inhibit tumor cell motility and invasiveness.
Hirano T; Satow R; Kato A; Tamura M; Murayama Y; Saya H; Kojima H; Nagano T; Okabe T; Fukami K
Biochem Pharmacol; 2013 Nov; 86(10):1419-29. PubMed ID: 24035834
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of microRNA-99a promotes cell invasion and down-regulates E-cadherin expression in pancreatic cancer cells by regulating mammalian target of rapamycin.
Li D; Li X; Cao W; Qi Y; Yang X
Acta Histochem; 2014 Jun; 116(5):723-9. PubMed ID: 24461517
[TBL] [Abstract][Full Text] [Related]
10. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
[TBL] [Abstract][Full Text] [Related]
12. Hmgb1 inhibits Klotho expression and malignant phenotype in melanoma cells by activating NF-κB.
Xie B; Cao K; Li J; Chen J; Tang J; Chen X; Xia K; Zhou X; Cheng Y; Zhou J; Xie H
Oncotarget; 2016 Dec; 7(49):80765-80782. PubMed ID: 27779100
[TBL] [Abstract][Full Text] [Related]
13. Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling.
Brouxhon SM; Kyrkanides S; Teng X; Athar M; Ghazizadeh S; Simon M; O'Banion MK; Ma L
Oncogene; 2014 Jan; 33(2):225-35. PubMed ID: 23318419
[TBL] [Abstract][Full Text] [Related]
14. H-cadherin expression reduces invasion of malignant melanoma.
Kuphal S; Martyn AC; Pedley J; Crowther LM; Bonazzi VF; Parsons PG; Bosserhoff AK; Hayward NK; Boyle GM
Pigment Cell Melanoma Res; 2009 Jun; 22(3):296-306. PubMed ID: 19368692
[TBL] [Abstract][Full Text] [Related]
15. Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail.
Hao L; Ha JR; Kuzel P; Garcia E; Persad S
Br J Dermatol; 2012 Jun; 166(6):1184-97. PubMed ID: 22332917
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors induce invasion of human melanoma cells in vitro via differential regulation of N-cadherin expression and RhoA activity.
Díaz-Núñez M; Díez-Torre A; De Wever O; Andrade R; Arluzea J; Silió M; Aréchaga J
BMC Cancer; 2016 Aug; 16(1):667. PubMed ID: 27549189
[TBL] [Abstract][Full Text] [Related]
17. SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway.
Yang N; Hui L; Wang Y; Yang H; Jiang X
Oncol Rep; 2014 Jun; 31(6):2651-9. PubMed ID: 24700142
[TBL] [Abstract][Full Text] [Related]
18. GSK3β inhibition blocks melanoma cell/host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation.
John JK; Paraiso KH; Rebecca VW; Cantini LP; Abel EV; Pagano N; Meggers E; Mathew R; Krepler C; Izumi V; Fang B; Koomen JM; Messina JL; Herlyn M; Smalley KS
J Invest Dermatol; 2012 Dec; 132(12):2818-27. PubMed ID: 22810307
[TBL] [Abstract][Full Text] [Related]
19. Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor.
Caporali S; Alvino E; Lacal PM; Levati L; Giurato G; Memoli D; Caprini E; Antonini Cappellini GC; D'Atri S
Int J Oncol; 2016 Sep; 49(3):1164-74. PubMed ID: 27572607
[TBL] [Abstract][Full Text] [Related]
20. Interplay between cadherins and α2β1 integrin differentially regulates melanoma cell invasion.
Siret C; Terciolo C; Dobric A; Habib MC; Germain S; Bonnier R; Lombardo D; Rigot V; André F
Br J Cancer; 2015 Nov; 113(10):1445-53. PubMed ID: 26512877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
